Search

… with English-only Labels for Use in Relation to the COVID-19 Pandemic Starting date: July 30, 2021 Posting date: July … Sale and Advertising of Drugs for Use in Relation to COVID-19 . Casirivimab and imdevimab, to be administered …

… authorized VEKLURY® (remdesivir) with conditions to treat COVID-19 in adults and adolescents with pneumonia requiring … of VEKLURY (remdesivir) worldwide, as a result of the COVID-19 pandemic. VEKLURY is the first drug that Health …

… Archived – Medication Errors Involving Reminyl and Amaryl – Janssen-Ortho Inc. and Aventis Pharma Inc. Starting date: … Images This is duplicated text of a letter from Janssen-Ortho Inc. & Aventis Pharma Inc. Contact the company … Directorate at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, OntarioM3C 1L9 Call toll-free at …

… Archived – Medication Errors Involving Reminyl and Amaryl –Janssen-Ortho Inc. and Aventis Pharma Inc. Starting date: … Images This is duplicated text of a letter from Janssen-Ortho Inc. & Aventis Pharma Inc. Contact the company … Directorate at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 Call toll-free …

… blocker (NMB) products in Canada as a result of the COVID-19 pandemic. Pancuronium Bromide Injection, USP is a … blocker (NMB) products in Canada as a result of the COVID-19 pandemic. Pancuronium Bromide Injection, USP is a …

… Rocuronium Bromide Injection in Canada as a result of the COVID-19 pandemic. Rocuronium Bromide Injection is a … Rocuronium Bromide Injection in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this …

… Reactions – For the Public Starting date: October 19, 2009 Posting date: October 19, 2009 Type of … is duplicated text of a letter from Tibotec, a division of Janssen-Ortho Inc . Contact the company for a copy of any … Severe Skin and Allergic Reactions Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in collaboration with Health …

… – Medication Errors Involving REMINYL and AMARYL® – Janssen-Ortho Inc. and Aventis Pharma Inc. Starting date: … RA-19000210 This is duplicated text of a letter from Janssen-Ortho Inc. and Aventis Pharma Inc. Contact the … Canada at the following addresses: Janssen-Ortho Inc. 19 Green Belt Drive Toronto, Ontario M3C 1L9 Or call toll …

… chloride injection USP) in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this product, … chloride injection USP) as a result of the COVID-19 pandemic. A limited quantity of US-labelled QUELICIN …

… Adverse Events in Placebo-Controlled Dementia Trials – Janssen-Ortho Inc. Starting date: October 11, 2002 Posting … RA-17000390 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … USA-63 1% (5/462) 1% (2/163) BEL-14 0% (0/20) 0% (0/19) Total 4% (29/764) 2% (7/466) Four patients died in the …

… Regarding Higher than Normal Blood Acid Levels – Janssen-Ortho Inc. – For the Public Starting date: January … RA-19000220 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … than Normal Blood Acid Levels Toronto, January 20, 2004 - Janssen-Ortho, following discussions with Health Canada, is …

… neuromuscular blocker (NMB), in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this product, … Rocuronium Bromide Injection in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this …

… Canada of Rocuronium Bromide Injection as a result of the COVID-19 pandemic. Rocuronium Bromide injection is a … Rocuronium Bromide Injection in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this …

… for Cisatracurium Besylate Injection as a result of the COVID-19 pandemic. Cisatracurium Besylate Injection is a … for Cisatracurium Besylate Injection, as a result of the COVID-19 pandemic. Given the medical necessity of this …